🔗 Permalink

Inventor profile of:

Benoît Moreau

City:

Newton, Massachusetts

Country:

United States

Published Applications:

38

Last publication date:

2025-12-25

Top Assignees for applications by Benoît Moreau

The entities that hold a legal rights for patent applications filed by inventor Moreau Benoît:

PLACON THERAPEUTICS, INC. 5 Cambridge, MA United States
Placon Therapeutics, Inc. 4 Watertown, MA United States
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 3 Ingelheim am Rhein, Germany
PLACON THERAPEUTICS 1 Watertown, MA United States
Tarveda Therapeutics, Inc. 1 Watertown, MA United States
Blend Therapeutics 1 Watertown, MA United States
Blend Therapeutics, Inc. 1 Watertown, MA United States
PLACON THERAPEUTICS, INC. 1 Camridge, MA United States

Recent patent applications by Moreau Benoît

Benoît Moreau from Newton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-25

US20250387492A1

Human necessities

HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF

#2 | 2025-10-30

US20250332173A1

Human necessities

COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING

#3 | 2025-10-23

US20250326748A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#4 | 2025-04-03

US20250109140A1

Chemistry; metallurgy

5-[5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#5 | 2025-03-20

US20250092065A1

Chemistry; metallurgy

2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#6 | 2025-03-13

US20250082633A1

Human necessities

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#7 | 2024-11-07

US20240366612A1

Human necessities

COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING

#8 | 2022-09-15

US20220288229A1

Human necessities

TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF

#9 | 2022-06-16

US20220185836A1

Chemistry; metallurgy

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS

#10 | 2022-03-31

US20220096640A1

Human necessities

HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF

#11 | 2022-02-03

US20220031853A1

Human necessities

HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF

#12 | 2021-05-20

US20210145971A1

Human necessities

HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF

#13 | 2021-01-07

US20210000966A1

Human necessities

HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF

#14 | 2020-04-23

US20200121808A1

Human necessities

SSTR-TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF

#15 | 2020-03-19

US20200085960A1

Human necessities

HSP90-targeting conjugates and formulations thereof

#16 | 2020-01-09

US20200009262A1

Human necessities

TARGETED CONSTRUCTS AND FORMULATIONS THEREOF

#17 | 2019-11-21

US20190350940A1

Human necessities

PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF

#18 | 2019-07-18

US20190218241A1

Chemistry; metallurgy

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS

#19 | 2019-05-02

US20190125888A1

Human necessities

TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF

#20 | 2019-01-17

US20190015378A1

Human necessities

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS

#21 | 2018-09-27

US20180273567A1

Chemistry; metallurgy

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF CANCERS

#22 | 2018-08-30

US20180243318A1

Human necessities

Platinum compounds, compositions, and uses thereof

#23 | 2018-07-05

US20180186823A1

Chemistry; metallurgy

PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF

#24 | 2018-01-25

US20180021454A1

Human necessities

TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF

#25 | 2018-01-11

US20180008614A1

Human necessities

Platinum compounds, compositions, and uses thereof

#26 | 2017-12-07

US20170349615A1

Chemistry; metallurgy

Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof

#27 | 2017-11-02

US20170313733A1

Chemistry; metallurgy

Compounds, compositions, and methods for the treatment of cancers

#28 | 2017-03-30

US20170087118A1

Human necessities

Compounds, compositions, and methods for the treatment of cancers

#29 | 2016-11-10

US20160326201A1

Chemistry; metallurgy

Compounds, compositions, and methods for the treatment of cancers

#30 | 2016-11-03

US20160318962A1

Chemistry; metallurgy

Compounds, compositions, and methods for the treatment of cancers

#31 | 2016-11-03

US20160317549A1

Human necessities

Platinum compounds, compositions, and uses thereof

#32 | 2016-06-02

US20160152646A1

Chemistry; metallurgy

Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof

#33 | 2016-03-10

US20160068557A1

Chemistry; metallurgy

Platinum compounds, compositions, and uses thereof

#34 | 2015-12-03

US20150344511A1

Chemistry; metallurgy

Compounds, compositions, and methods for the treatment of cancers

#35 | 2015-10-01

US20150274744A1

Chemistry; metallurgy

Inhibitors of cytomegalovirus

#36 | 2015-06-11

US20150158861A1

Chemistry; metallurgy

Cytomegalovirus inhibitor compounds

#37 | 2015-03-19

US20150080366A1

Chemistry; metallurgy

Cytomegalovirus inhibitor compounds

#38 | 2014-03-27

US20140088066A1

Chemistry; metallurgy

PLATINUM COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

InventorID:

704907 ⎘